Atlas Trials

Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD)

Clinical trial NCT03946085 · COMPLETED

Trial details

NCT number
NCT03946085
Sponsor
Guardion Health Sciences, Inc.
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Retinal DrusenAge-related Macular DegenerationMacular Degeneration
Start date
2018-01-19
Primary completion
2018-10-23
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.